Symlin Amylin Pharmaceuticals, Inc. - Treatment for Diabetes in conjunction with insulin

Symlin is a synthetic analog of human amylin, a naturally occurring hormone that is made in the beta cells of the pancreas. Symlin is used in conjunction with insulin to control glucose in patients with type 2 diabetes who use insulin, and in patients with type 1 diabetes.

Related Articles:

FDA Drug Approvals Archive

2010: Jan | Feb | Mar |
2009: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
2008: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
2004: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
2002: Aug | Oct | Dec |
(web9)